METOPROLOL TARTRATE INJECTION USP 1 MG
METOPROLOL TARTRATE : 1 MG · DIN 02455730 · STERIMAX INC
Health Canada status: APPROVED
What is METOPROLOL TARTRATE INJECTION USP?
METOPROLOL TARTRATE INJECTION USP 1 MG contains METOPROLOL TARTRATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02455730, held by STERIMAX INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 15-Jun-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02455730 |
|---|---|
| Brand name | METOPROLOL TARTRATE INJECTION USP |
| Generic / active ingredient | METOPROLOL TARTRATE : 1 MG |
| Manufacturer | STERIMAX INC |
| Strength | 1 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | C07AB02 METOPROLOL |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 15-Jun-2016 |
Is METOPROLOL in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C07AB02 METOPROLOL. 30 of 103 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-METOPROLOL SR | 100 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 02285169 |
| APO-METOPROLOL | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 00618640 |
| APO-METOPROLOL | 25 MG | TABLET | APOTEX INC | MARKETED | DIN 02246010 |
| APO-METOPROLOL | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 00618632 |
| APO-METOPROLOL (TYPE L) | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 00751170 |
| APO-METOPROLOL (TYPE L) | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 00749354 |
| JAMP-METOPROLOL-L | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02356848 |
| JAMP-METOPROLOL-L | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02356813 |
| JAMP-METOPROLOL-L | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02356821 |
| METOPROLOL | 100 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02350408 |
Who else supplies METOPROLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METOPROLOL appears in 449 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.